This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keating, S.
Right arrow Articles by Rowe, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keating, S.
Right arrow Articles by Rowe, M.

 Previous Article  |  Next Article 

Journal of Virology, August 2002, p. 8179-8188, Vol. 76, No. 16
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.16.8179-8188.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

The Lytic Cycle of Epstein-Barr Virus Is Associated with Decreased Expression of Cell Surface Major Histocompatibility Complex Class I and Class II Molecules

Sinéad Keating, Stuart Prince, Matthew Jones, and Martin Rowe*

Section of Infection and Immunity, University of Wales College of Medicine, Cardiff CF14 4XX, United Kingdom

Received 28 February 2002/ Accepted 10 May 2002

Human herpesviruses utilize an impressive range of strategies to evade the immune system during their lytic replicative cycle, including reducing the expression of cell surface major histocompatibility complex (MHC) and immunostimulatory molecules required for recognition and lysis by virus-specific cytotoxic T cells. Study of possible immune evasion strategies by Epstein-Barr virus (EBV) in lytically infected cells has been hampered by the lack of an appropriate permissive culture model. Using two-color immunofluorescence staining of cell surface antigens and EBV-encoded lytic cycle antigens, we examined EBV-transformed B-cell lines in which a small subpopulation of cells had spontaneously entered the lytic cycle. Cells in the lytic cycle showed a four- to fivefold decrease in cell surface expression of MHC class I molecules relative to that in latently infected cells. Expression of MHC class II molecules, CD40, and CD54 was reduced by 40 to 50% on cells in the lytic cycle, while no decrease was observed in cell surface expression of CD19, CD80, and CD86. Downregulation of MHC class I expression was found to be an early-lytic-cycle event, since it was observed when progress through late lytic cycle was blocked by treatment with acyclovir. The immediate-early transactivator of the EBV lytic cycle, BZLF1, did not directly affect expression of MHC class I molecules. However, BZLF1 completely inhibited the upregulation of MHC class I expression mediated by the EBV cell-transforming protein, LMP1. This novel function of BZLF1 elucidates the paradox of how MHC class I expression can be downregulated when LMP1, which upregulates MHC class I expression in latent infection, remains expressed in the lytic cycle.

* Corresponding author. Mailing address: Section of Infection and Immunity, University of Wales College of Medicine, Tenovus Building, Cardiff CF14 4XX, United Kingdom. Phone: 44 (0) 29 20 742579. Fax: 44 (0) 29 20 743868. E-mail: RoweM{at}cf.ac.uk.

Journal of Virology, August 2002, p. 8179-8188, Vol. 76, No. 16
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.16.8179-8188.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Li, D., Qian, L., Chen, C., Shi, M., Yu, M., Hu, M., Song, L., Shen, B., Guo, N. (2009). Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation. J. Immunol. 182: 1799-1809 [Abstract] [Full Text]  
  • Brooks, J. M., Lee, S. P., Leese, A. M., Thomas, W. A., Rowe, M., Rickinson, A. B. (2009). Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition. J. Immunol. 182: 1919-1928 [Abstract] [Full Text]  
  • Roder, G., Geironson, L., Bressendorff, I., Paulsson, K. (2008). Viral Proteins Interfering with Antigen Presentation Target the Major Histocompatibility Complex Class I Peptide-Loading Complex. J. Virol. 82: 8246-8252 [Full Text]  
  • Zuo, J., Thomas, W., van Leeuwen, D., Middeldorp, J. M., Wiertz, E. J. H. J., Ressing, M. E., Rowe, M. (2008). The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function. J. Virol. 82: 2385-2393 [Abstract] [Full Text]  
  • Wiertz, E. J., Devlin, R., Collins, H. L., Ressing, M. E. (2007). Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation. J. Virol. 81: 4389-4396 [Full Text]  
  • Rowe, M., Glaunsinger, B., van Leeuwen, D., Zuo, J., Sweetman, D., Ganem, D., Middeldorp, J., Wiertz, E. J. H. J., Ressing, M. E. (2007). Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc. Natl. Acad. Sci. USA 104: 3366-3371 [Abstract] [Full Text]  
  • Lagos, D., Trotter, M. W. B., Vart, R. J., Wang, H.-W., Matthews, N. C., Hansen, A., Flore, O., Gotch, F., Boshoff, C. (2007). Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 109: 1550-1558 [Abstract] [Full Text]  
  • Guerreiro-Cacais, A. O., Uzunel, M., Levitskaya, J., Levitsky, V. (2007). Inhibition of Heavy Chain and {beta}2-Microglobulin Synthesis as a Mechanism of Major Histocompatibility Complex Class I Downregulation during Epstein-Barr Virus Replication. J. Virol. 81: 1390-1400 [Abstract] [Full Text]  
  • Pappworth, I. Y., Wang, E. C., Rowe, M. (2007). The Switch from Latent to Productive Infection in Epstein-Barr Virus-Infected B Cells Is Associated with Sensitization to NK Cell Killing. J. Virol. 81: 474-482 [Abstract] [Full Text]  
  • Adhikary, D., Behrends, U., Moosmann, A., Witter, K., Bornkamm, G. W., Mautner, J. (2006). Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. JEM 203: 995-1006 [Abstract] [Full Text]  
  • Hahn, A. M., Huye, L. E., Ning, S., Webster-Cyriaque, J., Pagano, J. S. (2005). Interferon Regulatory Factor 7 Is Negatively Regulated by the Epstein-Barr Virus Immediate-Early Gene, BZLF-1. J. Virol. 79: 10040-10052 [Abstract] [Full Text]  
  • Ressing, M. E., Keating, S. E., van Leeuwen, D., Koppers-Lalic, D., Pappworth, I. Y., Wiertz, E. J. H. J., Rowe, M. (2005). Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection. J. Immunol. 174: 6829-6838 [Abstract] [Full Text]  
  • Johansson, S., Johansson, M., Rosmaraki, E., Vahlne, G., Mehr, R., Salmon-Divon, M., Lemonnier, F., Karre, K., Hoglund, P. (2005). Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. JEM 201: 1145-1155 [Abstract] [Full Text]  
  • Pudney, V. A., Leese, A. M., Rickinson, A. B., Hislop, A. D. (2005). CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. JEM 201: 349-360 [Abstract] [Full Text]  
  • Laichalk, L. L., Thorley-Lawson, D. A. (2005). Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo. J. Virol. 79: 1296-1307 [Abstract] [Full Text]  
  • Morrison, T. E., Mauser, A., Klingelhutz, A., Kenney, S. C. (2004). Epstein-Barr Virus Immediate-Early Protein BZLF1 Inhibits Tumor Necrosis Factor Alpha-Induced Signaling and Apoptosis by Downregulating Tumor Necrosis Factor Receptor 1. J. Virol. 78: 544-549 [Abstract] [Full Text]  
  • O'Connor, C. M., Damania, B., Kedes, D. H. (2003). De Novo Infection with Rhesus Monkey Rhadinovirus Leads to the Accumulation of Multiple Intranuclear Capsid Species during Lytic Replication but Favors the Release of Genome-Containing Virions. J. Virol. 77: 13439-13447 [Abstract] [Full Text]  
  • Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., Ottenhoff, T. H. M., Neefjes, J., Schumacher, T. N., Hutt-Fletcher, L. M., Wiertz, E. J. H. J. (2003). Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. USA 100: 11583-11588 [Abstract] [Full Text]  
  • Prince, S., Keating, S., Fielding, C., Brennan, P., Floettmann, E., Rowe, M. (2003). Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms. J. Virol. 77: 5000-5007 [Abstract] [Full Text]  
  • Mahot, S., Sergeant, A., Drouet, E., Gruffat, H. (2003). A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. 84: 965-974 [Abstract] [Full Text]  
  • Richardson, C., Fielding, C., Rowe, M., Brennan, P. (2003). Epstein-Barr Virus Regulates STAT1 through Latent Membrane Protein 1. J. Virol. 77: 4439-4443 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»